Effectiveness of immunosuppression minimisation, conversion or withdrawal strategies in paediatric solid organ and haematopoietic stem cell transplantation: a protocol of a systematic review and meta-analysis.
Carlos Martín SaboridoAlberto M BorobiaJavier CobasLorenzo D'AntigaEsteban FraucaFrancisco Hernández-OliverosPaloma JaraEduardo López-GranadosJose María MuñozEmanuele NicastroJose Jonay OjedaAntonio Pérez-MartínezJuan Manuel TorresAntonio CarcasPublished in: BMJ open (2020)
We will search the following databases with no language restrictions: Cochrane Central Register of Controlled Trials in the Cochrane Library, OvidSP Medline and Epub Ahead of Print, In-Process & Other Non-Indexed Citations and Daily; OvidSP Embase Classic+Embase; Ebsco CINAHL Plus, complete database; WHO International Clinical Trials Registry Platform search portal. We will include controlled and uncontrolled clinical trials along with any prospective or retrospective study that includes a universal cohort (all participants from a centre/region/city over a certain period). Cases series and cross-sectional studies are excluded. Two review authors will independently assess the trial eligibility, risk of bias and extract appropriate data points. The outcomes included in this review are: patient survival, acute graft rejection, chronic graft rejection, diabetes, graft function, graft loss, chronic graft versus host disease, acute graft versus host disease, surgical complications, infusion complications, post-transplant lymphoproliferative disease, liver function, renal function, cognition, depression, health-related quality of life, hospitalisation, high blood pressure, low blood pressure, cancer-other, cancer-skin, cardiovascular disease, bacterial infection, Epstein-Barr infection, cytomegalovirus infection, other viral infections and growth.
Keyphrases
- clinical trial
- blood pressure
- stem cell transplantation
- cardiovascular disease
- papillary thyroid
- liver failure
- randomized controlled trial
- cross sectional
- drug induced
- high dose
- type diabetes
- phase iii
- squamous cell
- phase ii
- heart rate
- hypertensive patients
- respiratory failure
- emergency department
- low dose
- intensive care unit
- systematic review
- big data
- depressive symptoms
- study protocol
- multiple sclerosis
- case report
- oxidative stress
- squamous cell carcinoma
- open label
- aortic dissection
- sars cov
- soft tissue
- physical activity
- adipose tissue
- glycemic control
- machine learning
- deep learning
- skeletal muscle
- double blind
- artificial intelligence
- blood glucose
- acute respiratory distress syndrome
- diffuse large b cell lymphoma
- single cell
- anti inflammatory